Scientists say Oxford Covid-19 vaccine is looking solid for older adults
The results, published in The Lancet, show the experimental shot generated an immune response in older people, who are at highest risk of severe illness
London — The University of Oxford confirmed that the Covid-19 vaccine it is developing with AstraZeneca produced strong immune responses in older adults in an early study, with pivotal findings from the final phase of trials expected in the coming weeks.
The results, published on Thursday in The Lancet medical journal, shed more light on preliminary data released in recent months showing the experimental shot generated an immune response in older people, who are at highest risk of severe illness. Researchers are still eagerly awaiting late-stage trial results that will show whether the Astra-Oxford vaccine can meet the high bar set by front-runners Pfizer and Moderna...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.